PMDA drug package insert
ボルベン輸液6%（シングルポート）
PMDA Prescription drug · フレゼニウス カービ ジャパン株式会社 · package insert Oct 26, 2025
Key facts
| Brand names | ボルベン輸液6%（シングルポート） |
|---|---|
| Nonproprietary names | ヒドロキシエチルデンプン１３００００ |
| Companies | 製造販売元／フレゼニウス カービ ジャパン株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 代用血漿剤 |
| Therapeutic category codes | 873319 |
| YJ codes | 3319408A1020 |
| Approval numbers | 22500AMX00876 |
| Package insert edition | 第2版 |
| Package insert date | Oct 26, 2025 |
| PMDA document key | 671147_3319408A1020_1 |
| PMDA company code | 671147 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: